RE:TH vs CYDYCYDY insider ownership is over 8% held by institutional investors 0.12% versus THTX 1.2% and over19% held by institutions.
Their daily average volume is over 4 million versus THTX's about 100k.So their trades comes mostly from retail investors why?
Because they early in the process saw the retail opportunity and surfed the retail tsunami well while THTX stubbornly refused to tap into that market.
jeffm34 wrote: TH would have to be trading at over $20 cnd to equal the market cap of CYDY. Cytodyne has 1 drug candidate in trials which if successful they hope will compete with Trogarzo. They already gave away 50% of their potential sales in a commercialization deal. The Covid trials are just a PR stunt. They have dozens of class action lawsuits pending against them. Last year end they lost over $100M and had zero revenue with about 15M cash.
TH already has 2 drugs producing sales, an oncology program with a massive potential market and a phase 3 NASH program. Yet we trade at 1/5 of what CYDY trades at. That tells you everything you need about the ability of our current BOD and management to get a real story out to the right people.